Author

Xilei Wang

Observed name: X. Wang

Institution: Shenzhen University

Observed institutions: Shenzhen University, Peking Union Medical College Hospital, First Affiliated Hospital of Guangdong Pharmaceutical University, Xuzhou Central Hospital

ORCID: 0009-0009-6950-4411

Observed ORCID: 0009-0009-6950-4411

OpenAlex ID: A5080500779

A fast, non-invasive auxiliary screening algorithm for lung cancer based on electronic nose system

2025 · Yongxiang Lin, Junhu Jing, et al. · Sensors and Actuators A Physical · 6

Performance-Enhanced Algorithm for Lung Cancer Screening Using Knowledge Distillation-Assisted Recurrent Neural Networks

2026 · Jiebin Chen, Xingzuo Song, et al. · IEEE Transactions on Instrumentation and Measurement · 1

Association Between Serum Vitamin D Levels and Biological Aging Acceleration: Evidence from NHANES 2017-2018

2024 · Feng Chen, Xilei Wang, et al. · Research Square · 1

OA09.05 A Phase 3 Study of Serplulimab Plus Chemotherapy as First-Line Treatment for Squamous Non-small-Cell Lung Cancer (ASTRUM-004)

2023 · C. Zhou, Y. Hu, et al. · Journal of Thoracic Oncology · 1

43P Camrelizumab plus famitinib as first-line treatment in advanced NSCLC patients with PD-L1 TPS ≥1%: A report from a multicenter, open-label, phase II basket trial

2023 · S. Ren, X. Wang, et al. · Journal of Thoracic Oncology · 1

1506P ctDNA testing based on deep NGS predicts treatment efficacy and prognosis in advanced pancreatic cancer patients

2024 · T. You, H. Tang, et al. · Annals of Oncology

Works count: 6

Citation count: 10

H-index: 1

I10-index: